Texas Health Fort Worth’s Jane and John Justin Tower Set to Open April 2

Texas Health Fort Worth’s Jane and John Justin Tower opening caps a more than two-year-long, $300 million construction project that adds 400,000 square feet to the hospital.

The nine-story tower, which includes 144 beds, 15 surgery suites, and new pre- and postoperative suites services, is the largest construction project in Texas Health history.

Justin Tower reinforces Texas Health’s long-standing commitment to the Fort Worth community,” said Barclay Berdan, FACHE, CEO of Texas Health Resources and a former president of Texas Health Fort Worth. “What began as a small community hospital has evolved into a world-class medical center serving the 12th largest city in the U.S.”

Justin Tower will increase surgical capacity by almost 30%, with dedicated neurosurgery and orthopedics operating suites. The surgical suites are twice the size of existing operating rooms (ORs) to accommodate modern robotic and imaging technology and are sized to accommodate even larger equipment in the future.

“Our service area includes 1.2 million people in four counties, and that’s expected to grow by another 100,000 over the next five years,” said Joseph DeLeon, president of Texas Health Fort Worth. “The larger, more modern facilities allow us to treat this growing population with specialty services, including trauma, neuroscience, heart and vascular, and many others.”

In addition to the ORs, additional elements of Justin Tower were built with an eye to the future. All patient rooms are private and can be modified to provide varying levels of care, from general medical-surgical to critical care. Additional design elements include the use of natural light, patient-friendly way-finding, and indoor and outdoor spaces for visitors.


Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy